Rui Batista

1.2k total citations
34 papers, 604 citations indexed

About

Rui Batista is a scholar working on Infectious Diseases, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, Rui Batista has authored 34 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Pediatrics, Perinatology and Child Health and 8 papers in Epidemiology. Recurrent topics in Rui Batista's work include Clostridium difficile and Clostridium perfringens research (11 papers), Gut microbiota and health (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Rui Batista is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (11 papers), Gut microbiota and health (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Rui Batista collaborates with scholars based in France, United States and Switzerland. Rui Batista's co-authors include Amélie Yavchitz, Carolina Riveros, Aïda Bafeta, Philippe Ravaud, Benjamin Davido, Aurélien Dinh, F. Chast, François Chast, Hugues Michelon and D. Huet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Rui Batista

32 papers receiving 588 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rui Batista France 13 249 192 111 100 66 34 604
Robert Janknegt Netherlands 13 248 1.0× 90 0.5× 223 2.0× 8 0.1× 39 0.6× 48 817
Simone Meini Italy 15 226 0.9× 135 0.7× 89 0.8× 6 0.1× 20 0.3× 41 755
Daoud Al‐Badriyeh Qatar 16 243 1.0× 29 0.2× 174 1.6× 136 1.4× 56 0.8× 95 805
Pablo Vidal Spain 13 78 0.3× 84 0.4× 152 1.4× 9 0.1× 78 1.2× 55 622
Kyle Vance‐Bryan United States 15 314 1.3× 62 0.3× 232 2.1× 5 0.1× 21 0.3× 35 886
Lars Småbrekke Norway 13 34 0.1× 57 0.3× 124 1.1× 10 0.1× 7 0.1× 43 483
Nicholas J. Mercuro United States 11 469 1.9× 90 0.5× 179 1.6× 73 0.7× 20 0.3× 27 817
Samah Alshehri Saudi Arabia 13 72 0.3× 67 0.3× 104 0.9× 8 0.1× 5 0.1× 39 565
Yazdan Mirzanejad Canada 13 183 0.7× 89 0.5× 356 3.2× 10 0.1× 11 0.2× 22 753
Emilio Maseda Spain 17 262 1.1× 65 0.3× 398 3.6× 7 0.1× 8 0.1× 83 1.1k

Countries citing papers authored by Rui Batista

Since Specialization
Citations

This map shows the geographic impact of Rui Batista's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Batista with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Batista more than expected).

Fields of papers citing papers by Rui Batista

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Batista. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Batista. The network helps show where Rui Batista may publish in the future.

Co-authorship network of co-authors of Rui Batista

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Batista. A scholar is included among the top collaborators of Rui Batista based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Batista. Rui Batista is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benech, Nicolas, Nadim Cassir, Laurent Alric, et al.. (2024). Impact of Clinical and Pharmacological Parameters on Faecal Microbiota Transplantation Outcome in Clostridioides difficile Infections: Results of a 5‐Year French National Survey. Alimentary Pharmacology & Therapeutics. 61(1). 159–167. 3 indexed citations
2.
Puszkiel, Alicja, Pascaline Boudou‐Rouquette, Jérôme Alexandre, et al.. (2023). Pazopanib pharmacokinetically guided dose optimization in three cancer patients with gastrointestinal resection. Cancer Chemotherapy and Pharmacology. 93(2). 169–175. 1 indexed citations
3.
Huillard, Olivier, Nihel Khoudour, Benoı̂t Blanchet, et al.. (2023). Cardiac toxicity associated with pharmacokinetic drug–drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report. British Journal of Clinical Pharmacology. 89(4). 1486–1490. 3 indexed citations
4.
Daniel, Thomas, et al.. (2023). Automated synthesis and quality control of [68Ga]Ga-PentixaFor using the Gaia/Luna Elysia-Raytest module for CXCR4 PET imaging. EJNMMI Radiopharmacy and Chemistry. 8(1). 4–4. 4 indexed citations
5.
Zerbit, Jérémie, Antoine Meyer, Justine Decroocq, et al.. (2022). Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron Era. Viruses. 14(11). 2377–2377. 15 indexed citations
6.
Contejean, Adrien, Salam Abbara, Sophie Alviset, et al.. (2022). Antimicrobial stewardship in high-risk febrile neutropenia patients. Antimicrobial Resistance and Infection Control. 11(1). 52–52. 23 indexed citations
7.
Bellesœur, Audrey, Anne Jouinot, Camille Tlemsani, et al.. (2021). Prevalence of drug–drug interactions in sarcoma patients: key role of the pharmacist integration for toxicity risk management. Cancer Chemotherapy and Pharmacology. 88(4). 741–751. 4 indexed citations
8.
Chouchana, Laurent, Inès Gana, Lucile Regard, et al.. (2020). Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients. Therapeutic Drug Monitoring. 43(1). 131–135. 9 indexed citations
9.
Abbara, Salam, Matthieu Domenech de Cellès, Rui Batista, et al.. (2019). Variable impact of an antimicrobial stewardship programme in three intensive care units: time-series analysis of 2012–2017 surveillance data. Journal of Hospital Infection. 104(2). 150–157. 4 indexed citations
10.
Davido, Benjamin, Rui Batista, Aurélien Dinh, et al.. (2019). Fifty shades of graft: How to improve the efficacy of faecal microbiota transplantation for decolonization of antibiotic-resistant bacteria. International Journal of Antimicrobial Agents. 53(5). 553–556. 12 indexed citations
11.
Davido, Benjamin, Rui Batista, Hafedh Fessi, et al.. (2018). Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak. Médecine et Maladies Infectieuses. 49(3). 214–218. 26 indexed citations
12.
Dinh, Aurélien, Hafedh Fessi, Clara Duran, et al.. (2018). Clearance of carbapenem-resistant Enterobacteriaceae vs vancomycin-resistant enterococci carriage after faecal microbiota transplant: a prospective comparative study. Journal of Hospital Infection. 99(4). 481–486. 59 indexed citations
13.
Gauzit, R., Solen Kernéis, Étienne Canouï, et al.. (2018). Assessing the benefit of the 72-hour antibiotic therapy reassessment documentation. Médecine et Maladies Infectieuses. 49(3). 187–193. 1 indexed citations
14.
Davido, Benjamin, Rui Batista, Hugues Michelon, et al.. (2017). Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?. Journal of Hospital Infection. 95(4). 433–437. 66 indexed citations
15.
Doré, Joël, Marie-Christine Multon, Jéhan‐Michel Béhier, et al.. (2017). Microbiote intestinal : qu’en attendre au plan physiologique et thérapeutique ?. Therapies. 72(1). 1–19.
16.
Longuet, P., Rui Batista, R. Gauzit, et al.. (2016). Preparing and administering injectable antibiotics: How to avoid playing God. Médecine et Maladies Infectieuses. 46(5). 242–268. 31 indexed citations
17.
Batista, Rui, Nathalie Kapel, J.C. Chaumeil, et al.. (2015). Le transfert de microbiote fécal lors d’infections récidivantes à Clostridium difficile. Cadre et aspects pharmacotechniques. Annales Pharmaceutiques Françaises. 73(5). 323–331. 5 indexed citations
18.
Caudron, Éric, et al.. (2007). Utilisation des médicaments achetés en ville par les patients hospitalisés. La Presse Médicale. 36(1). 15–19. 4 indexed citations
19.
Chast, F., et al.. (2004). Préparation d’un collyre de ciclosporine à 2 %. Journal Français d Ophtalmologie. 27(6). 567–576. 13 indexed citations
20.
Batista, Rui, et al.. (2004). Dosage plasmatique des énantiomères de la méthadone par chromatographie liquide à haute performance. Annales Pharmaceutiques Françaises. 62(3). 193–200. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Janknegt Breakdown of academic impact, for papers by Simone Meini Breakdown of academic impact, for papers by Daoud Al‐Badriyeh Breakdown of academic impact, for papers by Pablo Vidal Breakdown of academic impact, for papers by Kyle Vance‐Bryan Breakdown of academic impact, for papers by Lars Småbrekke Breakdown of academic impact, for papers by Nicholas J. Mercuro Breakdown of academic impact, for papers by Samah Alshehri Breakdown of academic impact, for papers by Yazdan Mirzanejad Breakdown of academic impact, for papers by Emilio Maseda
Rankless by CCL
2026